The upregulation of IGF2BP2 mRNA was further validated in fresh NSCLC samples and the paired adjacent non-tumor sites (Figure 1D, n = 24, p < 0.01). This evidence concerns the gene IGF2BP2 and non-small cell lung carcinoma.